Objective-To evaluate exercise capacity of patients with chronic atrial fibrillation in whom His bundle ablation followed by ventricular rate response pacing (WIR) was carried out because of drug refractoriness. Design-Prospective study. (1) angina pectoris of more than New York Heart Association (NYHA) class II (IV), (2) aortic or mitral valvar stenosis or incompetence, (3) respiratory diseases interfering with normal oxygen uptake, (4) any other abnormality interfering with the capability of performing a bicycle exercise test, and (5) paroxysmal atrial fibrillation.
VO2 at peak exercise did not change significantly. Maximum exercise capacity was achieved with a significantly lower maximum driven heart rate than the spontaneous heart rate before ablation. Conclusions-Exercise capacity of patients who underwent His bundle ablation followed by WIR pacing remained unchanged or improved during a mean follow up of seven months. Larger patient populations with longer follow up are necessary to examine determinants of improved exercise capacity.
(Heart 1997;77:238-241)
after His bundle ablation and ventricular rate response pacing (VVIR) for drug refractory chronic atrial fibrillation.
Methods

PATIENTS
This prospective study was performed between August 1993 and September 1994. Patients suffering from symptomatic or incapacitating atrial fibrillation selected for His bundle ablation were included. Exclusions were patients showing (1) angina pectoris of more than New York Heart Association (NYHA) class II (IV), (2) aortic or mitral valvar stenosis or incompetence, (3) respiratory diseases interfering with normal oxygen uptake, (4) any other abnormality interfering with the capability of performing a bicycle exercise test, and (5) paroxysmal atrial fibrillation.
PROCEDURES
Exercise testing with oxygen uptake measurement was performed to ensure that patients exercised maximally. Before exercise testing both routine spirometry and measurement of haemoglobin were performed, the echocardiographic left ventricular end diastolic dimension (LVEDD) and left atrial dimension were measured using the parasternal long axis, and valve abnormalities were looked for. After His bundle ablation and pacemaker implantation a standard chest x ray was taken to determine the position of the pacing lead and to permit calculation of the cardiothoracic ratio. Variables with a continuous distribution were expressed as mean values (SD). Differences were compared by means of a two tailed paired t test. For the linear regression a least square estimation after log transformation of the dependent variable was used.
Results
PATIENTS
Of 40 patients initially screened for participation in this study, 10 were excluded because of exclusion criteria (1) to (4) 
RESULTS OF EXERCISE TESTING
All patients were on antiarrhythmic drugs during the baseline exercise test. The second exercise test with VVIR pacing was performed at a mean interval of seven months after His bundle ablation and all patients were now free of antiarrhythmic drugs. The mean exercise capacity improved significantly from 109 W before to 118 W after the intervention (P = 0 002). The mean exercise duration also increased but not significantly (7 2 v 8-2 min).
Peak V02, however, defined as oxygen uptake at peak exercise, did not differ (19 0 v 18-9 ml/min/kg). The gas exchange anaerobic threshold, including the point at which carbon dioxide production increased disproportionally in relation to oxygen consumption and where there was a respiratory exchange ratio of > 1 0, was reached in all patients. Respiratory quotient as an objective measurement of maximum exercise capacity was adequate and did not differ significantly from before to after the procedure (1 19 v 1.21) . The mean maximum heart rate diminished significantly from mean of 153 beats/min to a mean of 130 ppm (P = 0o011).
After His bundle ablation the mean maximum heart rate was more than 90% of the programmed upper pacing limit in all patients, whereas 16 patients (64%) reached their programmed upper rate pacing limit (table 2) . Pacemaker parameters were programmed depending on age and assumed lifestyle. Patients with low exercise capacity before His bundle ablation were set to a lower upper rate pacing limit (120 ppm), in contrast to those with higher exercise capacity (150 ppm). In The figure shows the individual changes in exercise capacity after His bundle ablation and VVIR pacing as compared to the baseline condition. In all but one patient the exercise capacity remained stable (n = 12) or improved (n = 12). Some patients with a low baseline exercise capacity showed a marked improvement after the intervention, whereas other patients had no change at all. A logarithmic line was fitted, which models the trend of the expected improvement of exercise capacity in relation to the baseline exercise capacity.
To identify clinical characteristics possibly related to an improvement in exercise capacity a multivariate analysis of the duration of atrial fibrillation before ablation, peak V02, the cardiothoracic ratio, and the left ventricular end diastolic diameter was performed. This showed a favourable outcome for those patients having an LVEDD larger than 55 mm (P < 0002) but this was only observed in four patients.
Discussion
In this prospective study we examined the exercise capacity before and after His bundle ablation followed by VVIR pacing for drug refractory symptomatic chronic atrial fibrillation, using oxygen consumption as an objective tool. The results of this study show that there was a significant improvement in mean exercise capacity which was most marked in patients with the lowest exercise capacity during drug treated atrial fibrillation before the His bundle ablation (figure) (table 3),24 whereas a mean maximum driven heart rate of 130 ppm was obtained in our study. Further studies are needed to establish the optimal pacing parameters for the individual patient after His bundle ablation for drug refractory atrial fibrillation.
Changes of left ventricular function, and the discontinuation of antiarrhythmic drug treatment, and a general improvement in wellbeing are three possible causes of improved exercise capacity. Improvement of ejection fraction has been associated with improvement of exercise capacity,356 but a correlation between Vo2 measurement and indices of resting left ventricular function, such as ejection fraction, have not been established. 14 The measured value of peak V02, defined as oxygen uptake at maximum exercise, is generally accepted as an estimation of left ventricular function.'5 16 In our study this value remained unchanged after His bundle ablation and VVIR pacing, and therefore it is unclear whether an improvement of left ventricular function is crucial for better exercise capacity. However, improvement in exercise capacity was associated with a significantly lower driven heart rate compared to the preablation spontaneous heart rate. This finding can be partly explained by insufficiently controlled atrioventricular conduction with antiarrhythmic drugs during atrial fibrillation. In addition, a favourable effect on left ventricular function can be expected after withdrawal of antiarrhythmic drug treatment, eliminating side effects of drugs and possible negative inotropic effects. One might speculate that a more impaired left ventricular function might benefit more from this withdrawal. Finally, one may assume that improved wellbeing can result in higher exercise capacity. Up to now the contribution of any of theseor other-causes to improved exercise capacity remains uncertain and needs further investigation. CONCLUSION This study showed that exercise capacity of patients with VVIR pacing remained unchanged or improved during a mean follow up of seven months. In our view, larger patient populations with longer follow up are necessary to define the determinants of improved exercise capacity.
